Uromodulin as a Biomarker in Lupus Nephritis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University
About this trial
Evaluation of Uromodulin as a biomarker of renal histological activity/ Chronicity indices in lupus nephritis
Eligibility criteria
Qualifiers
• Group I: 30 patients with different classes of Lupus Nephritis. These cases are biopsy proven
Biopsy-proven lupus nephritis at the time of uromodulin blood sampling.
Group II: 10 patients with active SLE without renal involvement and with SLEDAI score ≥6
Group III: 10 patients with non-active SLE with SLEDAI score <6
Disqualifiers
• .Pregnancy or lactation
AKI secondary to pre renal OR post renal cause (from clinical history and imaging).
End-stage renal disease requiring dialysis
Active infection or sepsis
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov